Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York